Recent Security Class Actions
ContextLogic Inc. Class A Common Stock (NASDAQ: LOGC)
Company Name:ContextLogic Inc. Class A Common Stock
Stock Symbol:NASDAQ: LOGC
Class Period Start:12/03/2018
Class Period End (inclusive):02/10/2020
Filing Deadline:05/17/2020
According to the Complaint, LogicBio Therapeutics, Inc. purports to be a genome editing company, focused on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The Company’s lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia (“MMA”), a life-threatening disease that presents at birth.
